Total Payments
$202,577
2024 Payments
$88,923
Companies
34
Transactions
880
Medicare Patients
2,697
Medicare Billing
$144,367
Payment Breakdown by Category
Other$83,270 (41.1%)
Consulting$82,426 (40.7%)
Food & Beverage$16,704 (8.2%)
Travel$15,660 (7.7%)
Research$4,140 (2.0%)
Education$376.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $82,426 | 69 | 40.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78,466 | 62 | 38.7% |
| Food and Beverage | $16,704 | 678 | 8.2% |
| Travel and Lodging | $15,660 | 56 | 7.7% |
| Honoraria | $4,804 | 6 | 2.4% |
| Unspecified | $4,140 | 2 | 2.0% |
| Education | $376.89 | 7 | 0.2% |
Payments by Type
General
$198,437
878 transactions
Research
$4,140
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $59,721 | 132 | $0 (2024) |
| LEO Pharma Inc. | $36,733 | 106 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $35,826 | 104 | $0 (2024) |
| UCB, Inc. | $18,317 | 46 | $0 (2024) |
| GENZYME CORPORATION | $11,029 | 30 | $0 (2024) |
| Dermavant Sciences, Inc. | $8,240 | 60 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $7,743 | 44 | $0 (2024) |
| PFIZER INC. | $6,400 | 33 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $5,976 | 32 | $0 (2024) |
| EPI Health, LLC | $2,409 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88,923 | 315 | Arcutis Biotherapeutics, Inc. ($26,102) |
| 2023 | $56,217 | 241 | Lilly USA, LLC ($25,098) |
| 2022 | $37,264 | 179 | Lilly USA, LLC ($15,512) |
| 2021 | $20,173 | 145 | PFIZER INC. ($5,391) |
All Payment Transactions
880 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | LEO Pharma Inc. | ADBRY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $105.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Immunology | ||||||
| 11/09/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Consulting Fee | Cash or cash equivalent | $3,025.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/09/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Travel and Lodging | In-kind items and services | $748.45 | General |
| Category: DERMATOLOGY | ||||||
| 11/09/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Travel and Lodging | In-kind items and services | $340.85 | General |
| Category: DERMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CRISABOROLE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,140 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 856 | 1,626 | $342,573 | $45,752 |
| 2022 | 9 | 741 | 1,230 | $234,246 | $41,667 |
| 2021 | 11 | 541 | 774 | $144,566 | $30,836 |
| 2020 | 9 | 559 | 848 | $61,888 | $26,112 |
Total Patients
2,697
Total Services
4,478
Medicare Billing
$144,367
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 176 | 200 | $52,600 | $9,901 | 18.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 187 | 224 | $68,013 | $7,528 | 11.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 106 | 106 | $33,996 | $6,198 | 18.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 59 | 73 | $30,587 | $4,717 | 15.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 71 | 74 | $27,972 | $4,199 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 55 | $20,460 | $4,053 | 19.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 152 | 828 | $69,491 | $3,290 | 4.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $15,168 | $3,017 | 19.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 22 | $16,155 | $2,284 | 14.1% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 12 | $8,131 | $564.68 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 150 | $28,278 | $8,034 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 88 | $24,042 | $6,354 | 26.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 139 | 165 | $50,099 | $5,757 | 11.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 91 | 91 | $26,484 | $5,408 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $20,746 | $5,081 | 24.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 61 | 72 | $24,594 | $4,826 | 19.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 62 | 66 | $18,931 | $3,647 | 19.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 106 | 522 | $38,565 | $2,088 | 5.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 17 | $2,508 | $472.19 | 18.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 109 | $17,923 | $5,317 | 29.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 46 | 46 | $15,846 | $4,641 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 56 | $14,368 | $4,157 | 28.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 59 | 59 | $15,344 | $3,927 | 25.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 48 | 54 | $16,929 | $3,572 | 21.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 59 | 63 | $16,387 | $3,300 | 20.1% |
About Wendy Cantrell, CRNP
Wendy Cantrell, CRNP is a Adult Health healthcare provider based in Mountain Brk, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538100789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wendy Cantrell, CRNP has received a total of $202,577 in payments from pharmaceutical and medical device companies, with $88,923 received in 2024. These payments were reported across 880 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($82,426).
As a Medicare-enrolled provider, Cantrell has provided services to 2,697 Medicare beneficiaries, totaling 4,478 services with total Medicare billing of $144,367. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Mountain Brk, AL
- Active Since 06/09/2006
- Last Updated 04/04/2025
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1538100789
Products in Payments
- ADBRY (Biological) $30,606
- OLUMIANT (Drug) $30,483
- Zoryve (Drug) $26,102
- TALTZ (Drug) $19,105
- Bimzelx (Biological) $16,184
- DUPIXENT (Biological) $8,352
- TAPINAROF (Drug) $7,438
- EUCRISA (Drug) $4,502
- Ilumya (Biological) $3,765
- COSENTYX (Biological) $3,501
- WYNZORA (Drug) $2,375
- ILUMYA (Biological) $1,878
- TREMFYA (Drug) $1,417
- Cimzia (Drug) $1,126
- Sotyktu (Drug) $1,046
- CIBINQO (Drug) $817.77
- VTAMA (Drug) $801.66
- OPZELURA (Drug) $723.92
- SKYRIZI (Biological) $611.39
- RINVOQ (Biological) $355.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.